Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 143

1.

Results of First-round of Surveillance in Individuals at High-risk of Pancreatic Cancer from the AISP (Italian Association for the Study of the Pancreas) Registry.

Paiella S, Capurso G, Cavestro GM, Butturini G, Pezzilli R, Salvia R, Signoretti M, Crippa S, Carrara S, Frigerio I, Bassi C, Falconi M, Iannicelli E, Giardino A, Mannucci A, Laghi A, Laghi L, Frulloni L, Zerbi A; Italian Association for the Study of the Pancreas (AISP).

Am J Gastroenterol. 2018 Dec 11. doi: 10.1038/s41395-018-0414-z. [Epub ahead of print]

PMID:
30538291
2.

Systematic review and meta-analysis: Prevalence of incidentally detected pancreatic cystic lesions in asymptomatic individuals.

Zerboni G, Signoretti M, Crippa S, Falconi M, Arcidiacono PG, Capurso G.

Pancreatology. 2018 Nov 28. pii: S1424-3903(18)30761-0. doi: 10.1016/j.pan.2018.11.014. [Epub ahead of print]

PMID:
30503370
3.

Pancreatic cystic neoplasms: What is the most cost-effective follow-up strategy?

Maggi G, Guarneri G, Gasparini G, Fogliati A, Partelli S, Falconi M, Crippa S.

Endosc Ultrasound. 2018 Sep-Oct;7(5):319-322. doi: 10.4103/eus.eus_44_18. Review.

4.

Surveillance of Cystic Lesions of the Pancreas: Whom and How to Survey?

Andrianello S, Falconi M, Salvia R, Crippa S, Marchegiani G.

Visc Med. 2018 Jul;34(3):202-205. doi: 10.1159/000489240. Epub 2018 Jun 13. Review.

PMID:
30140686
5.

Correction: Long-term follow-up of low-risk branchduct IPMNs of the pancreas: is main pancreatic duct dilatation the most worrisome feature?

Petrone MC, Magnoni P, Pergolini I, Capurso G, Traini M, Doglioni C, Mariani A, Crippa S, Arcidiacono PG.

Clin Transl Gastroenterol. 2018 Aug 1;9(7):173. doi: 10.1038/s41424-018-0036-1.

6.

Long-term follow-up of low-risk branch-duct IPMNs of the pancreas: is main pancreatic duct dilatation the most worrisome feature?

Petrone MC, Magnoni P, Pergolini I, Capurso G, Traini M, Doglioni C, Mariani A, Crippa S, Arcidiacono PG.

Clin Transl Gastroenterol. 2018 Jun 13;9(6):158. doi: 10.1038/s41424-018-0026-3. Erratum in: Clin Transl Gastroenterol. 2018 Aug 1;9(7):173.

7.

Minimally Invasive Versus Open Treatment for Benign Sporadic Insulinoma Comparison of Short-Term and Long-Term Outcomes.

Belfiori G, Wiese D, Partelli S, W├Ąchter S, Maurer E, Crippa S, Falconi M, Bartsch DK.

World J Surg. 2018 Oct;42(10):3223-3230. doi: 10.1007/s00268-018-4628-4.

PMID:
29691623
8.

Pancreatic ductal adenocarcinoma in 2017: Time to change the therapeutic algorithm?

Crippa S, Piccioli A, Guarneri G, Longo E, Falconi M.

Endosc Ultrasound. 2017 Dec;6(Suppl 3):S62-S65. doi: 10.4103/eus.eus_61_17. No abstract available.

9.

Peptide receptor radionuclide therapy as neoadjuvant therapy for resectable or potentially resectable pancreatic neuroendocrine neoplasms.

Partelli S, Bertani E, Bartolomei M, Perali C, Muffatti F, Grana CM, Schiavo Lena M, Doglioni C, Crippa S, Fazio N, Zamboni G, Falconi M.

Surgery. 2018 Apr;163(4):761-767. doi: 10.1016/j.surg.2017.11.007. Epub 2017 Dec 25.

PMID:
29284590
10.

A Systematic review and meta-analysis on the role of palliative primary resection for pancreatic neuroendocrine neoplasm with liver metastases.

Partelli S, Cirocchi R, Rancoita PMV, Muffatti F, Andreasi V, Crippa S, Tamburrino D, Falconi M.

HPB (Oxford). 2018 Mar;20(3):197-203. doi: 10.1016/j.hpb.2017.10.014. Epub 2017 Nov 29. Review.

PMID:
29196022
11.

Systematic review and meta-analysis of prognostic role of splenic vessels infiltration in resectable pancreatic cancer.

Crippa S, Cirocchi R, Maisonneuve P, Partelli S, Pergolini I, Tamburrino D, Aleotti F, Reni M, Falconi M.

Eur J Surg Oncol. 2018 Jan;44(1):24-30. doi: 10.1016/j.ejso.2017.10.217. Epub 2017 Nov 20. Review.

PMID:
29183639
12.

Pancreatic enzyme replacement therapy after gastric resection: An update.

Antonini F, Crippa S, Falconi M, Macarri G, Pezzilli R.

Dig Liver Dis. 2018 Jan;50(1):1-5. doi: 10.1016/j.dld.2017.10.025. Epub 2017 Nov 10. Review.

PMID:
29170072
13.

SUVmax after (18)fluoro-deoxyglucose positron emission tomography/computed tomography: A tool to define treatment strategies in pancreatic cancer.

Pergolini I, Crippa S, Salgarello M, Belfiori G, Partelli S, Ruffo G, Pucci A, Zamboni G, Falconi M.

Dig Liver Dis. 2018 Jan;50(1):84-90. doi: 10.1016/j.dld.2017.09.122. Epub 2017 Sep 22.

PMID:
29017830
14.

Response to Malleo et al.

Crippa S, Pezzilli R, Capurso G, Ruffo G, Falconi M.

Am J Gastroenterol. 2017 Sep;112(9):1481-1482. doi: 10.1038/ajg.2017.204. No abstract available.

PMID:
28874865
15.

Diagnosis and treatment in chronic pancreatitis: an international survey and case vignette study.

Issa Y, van Santvoort HC, Fockens P, Besselink MG, Bollen TL, Bruno MJ, Boermeester MA; Collaborators.

HPB (Oxford). 2017 Nov;19(11):978-985. doi: 10.1016/j.hpb.2017.07.006. Epub 2017 Aug 15.

16.

A preoperative score to predict early death after pancreatic cancer resection.

Balzano G, Dugnani E, Crippa S, Scavini M, Pasquale V, Aleotti F, Liberati D, Gandolfi A, Belfiori G, Reni M, Doglioni C, Ruffo G, Marmorale C, Falconi M, Piemonti L.

Dig Liver Dis. 2017 Sep;49(9):1050-1056. doi: 10.1016/j.dld.2017.06.012. Epub 2017 Jul 1.

PMID:
28734776
17.

Pancreatic Adenocarcinoma: Improving Prevention and Survivorship.

Sohal DPS, Willingham FF, Falconi M, Raphael KL, Crippa S.

Am Soc Clin Oncol Educ Book. 2017;37:301-310. doi: 10.14694/EDBK_175222. Review.

18.

Early Postoperative Prediction of Clinically Relevant Pancreatic Fistula after Pancreaticoduodenectomy: usefulness of C-reactive Protein.

Partelli S, Pecorelli N, Muffatti F, Belfiori G, Crippa S, Piazzai F, Castoldi R, Marmorale C, Balzano G, Falconi M.

HPB (Oxford). 2017 Jul;19(7):580-586. doi: 10.1016/j.hpb.2017.03.001. Epub 2017 Apr 7.

19.

Active Surveillance Beyond 5 Years Is Required for Presumed Branch-Duct Intraductal Papillary Mucinous Neoplasms Undergoing Non-Operative Management.

Crippa S, Pezzilli R, Bissolati M, Capurso G, Romano L, Brunori MP, Calculli L, Tamburrino D, Piccioli A, Ruffo G, Fave GD, Falconi M.

Am J Gastroenterol. 2017 Jul;112(7):1153-1161. doi: 10.1038/ajg.2017.43. Epub 2017 Feb 28.

PMID:
28244498
20.

Management of neuroendocrine carcinomas of the pancreas (WHO G3): A tailored approach between proliferation and morphology.

Crippa S, Partelli S, Belfiori G, Palucci M, Muffatti F, Adamenko O, Cardinali L, Doglioni C, Zamboni G, Falconi M.

World J Gastroenterol. 2016 Dec 7;22(45):9944-9953. doi: 10.3748/wjg.v22.i45.9944. Review.

Supplemental Content

Loading ...
Support Center